Abstract:Background: We aimed to compare the antipyretic efficacy, safety, and tolerability between oral dexibuprofen and intravenous propacetamol in children with upper respiratory tract infection (URTI) presenting with fever. Methods: Patients aging from 6 months to 14 years admitted for URTI with axillary body temperature ≥ 38.0 °C were enrolled and randomized into the study or control group. Patients in the study group were intravenously infused with propacetamol and subsequently oral placebo medication was administered. Patients in the control group were intravenously infused with 100 mL of 0.9% sodium chloride solution without propacetamol and then oral dexibuprofen was administered. We checked the body temperature of all patients at 0.5 h (hr), 1 h, 1.5 h, 2 h, 3 h, 4 h, and 6 h after oral placebo or dexibuprofen had been applied. Results: A total of 263 patients (125 in the study group) were finally enrolled. The body temperatures of patients in the study group were significantly lower until 2 h after administration (37.73 ± 0.58 vs 38.36 ± 0.69 °C (p < 0.001), 37.37 ± 0.53 vs 37.88 ± 0.69 °C (p < 0.001), 37.27 ± 0.60 vs 37.62 ± 0.66 °C (p < 0.001), 37.25 ± 0.62 vs 37.40 ± 0.60 °C (p = 0.0452), at 0.5 h, 1 h, 1.5 h, and 2 h, respectively). The two groups showed no significant differences in terms of the range of body temperature decrease, the Area Under the Curve of body temperature change for antipyretic administration-and-time relationship, the maximum value of body temperature decrease during the 6 h test period, the number of patients whose body temperature normalized (< 37.0 °C), the mean time when first normalization of body temperature, and the development of adverse events including gastrointestinal problem, elevated liver enzyme, and thrombocytopenia. Conclusions: Intravenous propacetamol may be a safe and effective choice for pediatric URTI patients presenting with fever who are not able to take oral medications or need faster fever control. Trial registration: CRIS KCT0002888 . Date of registration: July 31st, 2013.

Formulation and evaluation of Chewable tablets Containing Dexibuprofen as an Antipyretic Drug

Evaluation of the antipyretic and anti-inflammatory potential of aqueous fruit pulp extract of Terminalia bellirica (Combretaceae) v1

Development and Evaluation of Carminative Herbal Chewable Tablets Based on Turmeric, Fennel Seed, and Mango Ginger

Exploring the synergistic effect in polyherbal chewable antacid tablets: formulation and evaluation study

FORMULATION AND EVALUATION OF ORAL FAST DISINTEGRATING TABLET OF IBUPROFEN USING TWO SUPER DISINTEGRANTS

A child-friendly anti-infective gummy formulation: Design, physicochemical, micromechanical, and taste sensory evaluation

Formulation and In -Vitro Evaluation of Metoclopramide Hydrochloride Chewable Tablets

Formulation and evaluation of chewable tablets of Desloratadine prepared by aqueous and non-aqueous techniques

Preparation and Evaluation of Chewable Tablets of Syzygium cumini Seed Powder

A Study on Chewable Tablets for the Anti-Allergic Drug

Preparation and Evaluation of Diclofenac Sodium Effervescent Tablet

The effects and safety of dexibuprofen compared with ibuprofen in febrile children caused by upper respiratory tract infection

Formulation Development and Evaluation of Taste Masked Anthelmintics Chewable Tablets by Using Fluid Bed Processor Technique

FORMULATION, IN VITRO, AND IN VIVO EVALUATION OF TASTE-MASKED ORAL DISINTEGRATING TABLETS OF FEXOFENADINE HYDROCHLORIDE USING SEMISYNTHETIC AND NATURAL SUPERDISINTEGRANTS

Development of Denticap, a matrix based sustained release formulation for treatment of toothache, dental infection and other gum problem

The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial

Formulation Development, Characterization, and Evaluation of a Novel Dexibuprofen-Capsaicin Skin Emulgel with Improved In Vivo Anti-inflammatory and Analgesic Effects

Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique

Formulation and Evaluation of Chewable Tablets of Anti-Asthmatic Drug

Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics

Formulation and Evaluation of Ceftazidime Chewable Tablets